Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Current Opinion in Structural Biology|February 19, 2000
Amyloid fibrillogenesis: themes and variationsJ C Rochet, P T LansburyBiochemistry|September 9, 2000
Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synucleinJ C Rochet, K A Conway, P T LansburyScience (New York, N.Y.)|November 10, 2001
Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adductK A Conway, J C Rochet, R M Bieganski, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapyK A Conway, S J Lee, J C Rochet, et al.Arzneimittel-Forschung|March 1, 1995
Consequences of the molecular mechanism of amyloid formation for the understanding of the pathogenesis of Alzheimer's disease and the development of therapeutic strategiesP T LansburyCurrent Opinion in Chemical Biology|August 1, 1997
Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's diseaseP T LansburyBiochemistry|June 27, 2001
Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's diseaseM J Volles, S J Lee, J C Rochet, et al.Chemistry & Biology|January 1, 1995
The chemistry of scrapie infection: implications of the 'ice 9' metaphorP T Lansbury, B CaugheyBiochemistry|December 25, 1992
Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmBJ T Jarrett, P T LansburyPageof 5